Acquisition · Healthcare & Life Sciences

Temple buys British longevity clinic Longevous

By Startup Enthusiast · 27 August 2026

What they do

Temple creates a temple-mounted wearable sensor measuring brain blood circulation, oxygen levels, and metabolic demand

Deepinder Goyal's venture bought London longevity clinic Longevous for an unstated price, absorbing its two founding doctors

The transaction secures Temple an operating base inside Britain while it prepares initial consumer hardware shipments

Temple bought London clinic Longevous for an unrevealed price.
Longevous co-founders Dr Robert Mohr and Dr Avi Roy joined the buyer as full-time staff.
Dr Mohr assumed the role of Chief Medical Officer at Temple.
Dr Roy took charge of scientific initiatives as Head of Science.
Longevous keeps running under Temple, allowing both practitioners to keep advising existing patients.
The agreement grew out of a London dinner where the physicians spotted the forehead device worn by Deepinder Goyal.
Temple plans to open pre-orders soon and deliver units before 2026 concludes.

The purchase hands Temple an immediate foothold across the United Kingdom preventive healthcare landscape.
Longevity medicine prioritises sustained wellness, early risk screening, and science-backed healthy ageing over standard disease intervention.
Both incoming doctors evaluated the hardware for two months and scrutinized its core biological assumptions.

Temple builds a health sensor positioned on the side of the forehead instead of the wrist.
The tracker records cerebral blood flow, oxygen saturation, and pulse variations during exercise, sleep, and rest.
Its bespoke metric Entropy gauges bodily exertion and autonomic nervous demand on a scale from 1 to 250.
The firm notes the hardware is sold for general wellness rather than clinical diagnosis or therapy.
Manufacturing tie-ups with Zetwerk and Ethereal Machines support early hardware fabrication.

Open advance orders for a limited introductory hardware edition.
Ship initial wearable units to customers prior to the close of 2026.
Produce an initial batch of several thousand devices for domestic and overseas distribution.

Product: A brain-monitoring wearable device designed to track health metrics.
Customers: Individual consumers interested in health and brain-monitoring technology.
How it makes money: Direct sale of wearable hardware devices to consumers.
What sets it apart: Claims to be the smallest wearable device on the market.
Operations: Manufacturing is outsourced to partners like Zetwerk and Ethereal Machines.